NaaS Technology Secured Investment from TAMP Giant Envestnet's Mutual Fund
SEC Form 13F is a quarterly holdings disclosure mandated by the U.S. Securities and Exchange Commission (SEC) for US-based institutional investors managing over
Envestnet (ENV.US) is one of the world's largest global TAMP platforms, and Envestnet PMC is part of the company's wealth management solutions business.
Envestnet's Quantitative Research Group (QRG) manages PMDEX using a factor-based approach that aims to give exposure to asset pricing factors that academic research has indicated to be the primary drivers of excess return. PMDEX's allocations to global equities follow PMC's asset class portfolio weightings for an aggressive (i.e., 100% equity) model. The fund has allocated for NaaS within its consumer retail category alongside other prominent companies such as Amazon, Pinduoduo, JD.com, and Alibaba.
The booming Chinese new energy vehicle market has continued to attract institutional attention to NaaS, which is positioned in the fast-growing sector. Notably, the WilderHill Clean Energy ETF (PBW), managed by renowned global asset management firm Invesco, and the Fidelity NASDAQ Composite Index Fund (FNCMX) both increased their positions in NaaS during the fourth quarter of 2023. Additionally, active climate change-focused ETF funds such as Carbon Collective Climate Solutions
Moreover, several domestic and international index companies, including the China Securities Index, Wind Information, and BITA, have incorporated NaaS into various indices, signaling NaaS' steadily increasing global recognition and influence.
About NaaS Technology Inc.
NaaS Technology Inc. is the first
For investor and media inquiries, please contact:
Investor Relations
NaaS Technology Inc.
E-mail: [email protected]
Media inquiries:
E-mail: [email protected]
View original content:https://www.prnewswire.com/news-releases/naas-technology-secured-investment-from-tamp-giant-envestnets-mutual-fund-302051937.html
SOURCE NaaS Technology Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Revelation Biosciences picks Avance Clinical for kidney injury trial
- A2Z Cust2Mate gets follow-on order for 1,050 smart carts from HaStock
- Cosmos Health posts 29% revenue rise in Q2 but net loss widens
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share